OverviewSuggest Edit

TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options. The Company is focused on the commercialization of the Senhance Surgical Robotic System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye sensing camera control. The Company also developed the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical platform.

TypePublic
Founded2006
HQMorrisville, US
Websitetransenterix.com
Employee Ratings3.2

Latest Updates

Employees (est.) (Dec 2019)160(-8%)
Job Openings2
Revenue (FY, 2019)$8.5 M(-64%)
Share Price (Sept 2020)$0.3
Cybersecurity ratingBMore

Key People/Management at TransEnterix

Wouter Donders

Wouter Donders

General Manager, EMEA / CIS
Joshua Weingard

Joshua Weingard

Chief Legal Officer
Kathleen Frost

Kathleen Frost

Vice President, Intellectual Property
Anthony Fernando

Anthony Fernando

President and Chief Executive Officer
Todd M. Pope

Todd M. Pope

Board of Director
Show more

TransEnterix Office Locations

TransEnterix has offices in Morrisville, Milano, Chiyoda City, Bertrange and in 2 other locations
Morrisville, US (HQ)
635 Davis Dr #300
Milano, IT
Viale dell’Innovazione 3
Chiyoda City, JP
building, 5th floor, 1-chōme-3-5 Kōjimachi
Bertrange, LU
33 Rue du puits Romain
Singapore, SG
8 Shenton Way, #05-02 AXA Tower
Lugano, CH
Via Serafino Balestra 12
Show all (6)

TransEnterix Financials and Metrics

TransEnterix Revenue

TransEnterix's revenue was reported to be $8.53 m in FY, 2019
USD

Revenue (Q2, 2020)

655.0k

Gross profit (Q2, 2020)

(758.0k)

Gross profit margin (Q2, 2020), %

(115.7%)

Net income (Q2, 2020)

(13.8m)

EBIT (Q2, 2020)

(14.4m)

Market capitalization (14-Sept-2020)

34.3m

Closing stock price (14-Sept-2020)

0.3

Cash (30-Jun-2020)

15.6m

EV

21.5m
TransEnterix's current market capitalization is $34.3 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

35.0k1.4m401.0k1.5m7.1m24.1m8.5m

Revenue growth, %

(72%)(100%)

Cost of goods sold

382.0k4.8m1.1m1.1m6.7m16.2m20.7m

Gross profit

(347.0k)(3.4m)(694.0k)450.0k384.0k7.9m(12.2m)
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

9.0k11.0k11.0k6.0k362.0k93.0k113.0k61.0k1.5m1.9m1.6m183.0k4.8m6.4m5.4m2.2m3.6m2.0m600.0k655.0k

Cost of goods sold

171.0k8.0k4.0k3.0k2.1m220.0k238.0k202.0k1.0m1.3m972.0k921.0k2.6m3.7m4.2m2.5m3.9m3.4m1.7m1.4m

Gross profit

(162.0k)3.0k7.0k3.0k(1.7m)(127.0k)(125.0k)(141.0k)435.0k612.0k612.0k(738.0k)2.2m2.7m1.2m(286.0k)(297.0k)(1.4m)(1.1m)(758.0k)

Gross profit Margin, %

(1800%)27%64%50%(469%)(137%)(111%)(231%)30%31%39%(403%)46%42%22%(13%)(8%)(70%)(190%)(116%)
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

298.0k275.0k10.0m34.8m38.4m24.2m91.2m21.1m9.6m

Accounts Receivable

12.0k188.0k133.0k76.0k621.0k1.5m8.6m620.0k

Prepaid Expenses

143.0k140.0k593.0k789.0k6.7m9.3m9.2m

Inventories

1.6m701.0k7.9m10.8m10.9m10.7m
USDQ2, 2011

Financial Leverage

1.4 x
Show all financial metrics

TransEnterix Operating Metrics

FY, 2016

Patent Applications

40

Patents Issued

19
Show all operating metrics

TransEnterix Cybersecurity Score

Cybersecurity ratingPremium dataset

B

80/100

SecurityScorecard logo

TransEnterix Online and Social Media Presence

Embed Graph

TransEnterix News and Updates

Surgical Robot Market Future Outlook Accuray, Stryker Corporation, TransEnterix, Intuitive, and Hocoma

WiseGuyRerports.com Presents “Surgical Robot Market, By Product (Robot Systems, Instrument & Accessories and Services), By Brands, By Application and Geography” New Document to its Studies Database Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Surgical Robots Market Report 2020 Top Companies- Intuitive Surgical, Stryker, Medtech, TransEnterix, THINK Surgical and more...

A new market study, titled “Global Surgical Robots Market Growth 2020-2025”, has been featured on WiseGuyReports. Posted via Industry Today. Follow us on Twitter @IndustryToday

Global Medical Devices Pipeline Assessment for Endoscopic Instruments 2020, Featuring Agile EndoSurgery Inc, AridoEndo and TransEnterix Inc

DUBLIN, May 21, 2020 /PRNewswire/ -- The "Endoscopic Instruments - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of Endoscopic Instruments currently in pipeline stage. The report provides...

TransEnterix hopes to raise $20.3M in public offering for surgical robotics

TransEnterix is publicly offering stock after regulatory approvals of its Senhance robotic surgical system and disappointing financial results. The post TransEnterix hopes to raise $20.3M in public offering for surgical robotics appeared first on Design World.

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating TransEnterix, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

NEW YORK, March 19, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of TransEnterix, Inc. (NYSE American: TRXC). If...

Expanding Scope on Robotic Surgical Systems Market 2019-2025: Global Companies like Intuitive Surgical, Transenterix, Johnson&Johnson, Hansen Medical, MEDTECH, Titan Medical, Microbot Medical

Robotic Surgical Systems Market from Qurate’s Repository provides detailed information, in depth analysis and forecast which is developed by team of experts and professionals. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

TransEnterix Blogs

TransEnterix Announces Maastricht University Medical Center+ in the Netherlands to Initiate Program with the Senhance Surgical System

TransEnterix Announces Maastricht University Medical Center+ in the Netherlands to Initiate Program with the Senhance Surgical System Content Import Mon, 07/27/2020 - 06:50 TransEnterix Announces Maastricht University Medical Center+ in the Netherlands to Initiate Program with the Senhance…

TransEnterix Schedules Second Quarter Financial and Operating Results Conference Call for August 5, 2020

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jul. 22, 2020-- TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release second quarter financial and operating results after the market closes on Wednesday, August 5, 2020 . The Company will host a conference call to discuss

TransEnterix Announces Closing of $15.0 Million Underwritten Public Offering including Full Exercise of Over-Allotment Option

TransEnterix Announces Closing of $15.0 Million Underwritten Public Offering including Full Exercise of Over-Allotment Option Content Import Mon, 07/06/2020 - 16:05 TransEnterix Announces Closing of $15.0 Million Underwritten Public Offering including Full Exercise of Over-Allotment Option…

TransEnterix Announces Pricing of $13.0 Million Underwritten Public Offering of Common Stock

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jul. 1, 2020-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it has priced its previously announced

TransEnterix Announces Launch of Underwritten Public Offering of Common Stock

TransEnterix Announces Launch of Underwritten Public Offering of Common Stock Content Import Tue, 06/30/2020 - 16:15 TransEnterix Announces Launch of Underwritten Public Offering of Common Stock June 30, 2020 at 4:15 PM EDT This release is a backfill from a Ne…

TransEnterix Announces Sana Klinikum Offenbach to Initiate Program with the Senhance Surgical System

TransEnterix Announces Sana Klinikum Offenbach to Initiate Program with the Senhance Surgical System Content Import Tue, 06/23/2020 - 06:55 TransEnterix Announces Sana Klinikum Offenbach to Initiate Program with the Senhance Surgical System June 23, 2020 at 6:55 AM EDT …
Show more

TransEnterix Frequently Asked Questions

  • When was TransEnterix founded?

    TransEnterix was founded in 2006.

  • Who are TransEnterix key executives?

    TransEnterix's key executives are Wouter Donders, Joshua Weingard and Kathleen Frost.

  • How many employees does TransEnterix have?

    TransEnterix has 160 employees.

  • What is TransEnterix revenue?

    Latest TransEnterix annual revenue is $8.5 m.

  • What is TransEnterix revenue per employee?

    Latest TransEnterix revenue per employee is $53.3 k.

  • Who are TransEnterix competitors?

    Competitors of TransEnterix include Intuitive Surgical, Orthotaxy and ValueBioTech.

  • Where is TransEnterix headquarters?

    TransEnterix headquarters is located at 635 Davis Dr #300, Morrisville.

  • Where are TransEnterix offices?

    TransEnterix has offices in Morrisville, Milano, Chiyoda City, Bertrange and in 2 other locations.

  • How many offices does TransEnterix have?

    TransEnterix has 6 offices.